Traditional and Newer Therapeutic Options for Psoriatic Arthritis
- 1 January 2005
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 65 (9), 1223-1238
- https://doi.org/10.2165/00003495-200565090-00004
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progressionArthritis & Rheumatism, 2004
- Serum MMP-1 and TIMP-1 levels are increased in patients with psoriatic arthritis and their siblingsRheumatology, 2003
- HLA is a candidate region for psoriatic arthritis: evidence for excessive HLA sharing in sibling pairsHuman Immunology, 2003
- RANKL and RANK as novel therapeutic targets for arthritisCurrent Opinion in Rheumatology, 2003
- Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatmentAnnals Of The Rheumatic Diseases, 2002
- Etanercept (Enbrel): update on therapeutic useAnnals Of The Rheumatic Diseases, 2000
- Leflunomide: mode of action in the treatment of rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2000
- The Immunological Synapse: A Molecular Machine Controlling T Cell ActivationScience, 1999
- Mechanism of Action of Mycophenolate MofetilTherapeutic Drug Monitoring, 1995
- Psoriatic arthritis: One year of treatment with extracorporeal photochemotherapyJournal of the American Academy of Dermatology, 1994